Yokohama, Japan

Shigeharu Inoje

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeharu Inoje. Retrieved from https://idiyas.com/inventor/shigeharu-inoje

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Shigeharu Inoje

Introduction

Shigeharu Inoje is a notable inventor based in Yokohama, Japan, recognized for his contributions to the field of antibiotics. With a focus on developing efficient processes for pharmaceutical production, his work has significant implications for healthcare and medicine.

Latest Patents

Inoje holds a patent for his invention titled "Process for preparing a cephamycin type antibiotic substance." This innovative process involves cultivating a microorganism belonging to the genus Streptomyces under aerobic conditions. A primary objective of this invention is to provide a streamlined method for producing the antibiotic on a simple and industrial scale, which is crucial for meeting the growing demand in the pharmaceutical industry.

Career Highlights

Shigeharu Inoje's career has been significantly enriched by his association with Meiji Seika Kaisha, Ltd. Here, he has utilized his expertise to advance both his own research and the company’s objectives in developing biopharmaceutical products. His work has placed him at the forefront of antibiotic innovation, enabling advancements that are expected to benefit public health significantly.

Collaborations

Inoje collaborates closely with colleagues Takashi Shomura and Hiroshi Watanabe. Together, they share a commitment to research excellence and innovation in antibiotic synthesis, driving their shared goals forward and enhancing the overall productivity of their research initiatives.

Conclusion

Shigeharu Inoje's contributions to the development of cephamycin type antibiotic substances showcase his dedication to innovation in the pharmaceutical field. His patent represents a significant achievement in creating efficient production processes that can have a positive impact on healthcare. As he continues his work at Meiji Seika Kaisha, Ltd., the medical community eagerly anticipates further advancements stemming from his research and collaborative efforts.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…